Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood Cancer J 2024 Mar 05;14(1):36
Date
03/06/2024Pubmed ID
38443341Pubmed Central ID
PMC10914796DOI
10.1038/s41408-024-01023-9Scopus ID
2-s2.0-85186936720 (requires institutional sign-in at Scopus site)Author List
Gong Z, Umoru G, Monge J, Shah N, Mohyuddin GR, Radhakrishnan SV, Chakraborty R, Rasche L, Schinke C, D'Souza A, Mohan MAuthors
Anita D'Souza MD Associate Professor in the Medicine department at Medical College of WisconsinMeera Mohan MD Assistant Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
B-Cell Maturation AntigenHumans
Multiple Myeloma
T-Lymphocytes